BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34874346)

  • 1. Prognostic Value of Interim 18F-DOPA and 18F-FDG PET/CT Findings in Stage 3-4 Pediatric Neuroblastoma.
    Ko KY; Yen RF; Ko CL; Chou SW; Chang HH; Yang YL; Jou ST; Hsu WM; Lu MY
    Clin Nucl Med; 2022 Jan; 47(1):21-25. PubMed ID: 34874346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Metabolic Parameters and Textural Features in Pretreatment
    Wang G; Si Y; Liu J; Wang W; Yang J
    Acad Radiol; 2024 Mar; 31(3):1091-1101. PubMed ID: 37748956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Stratification of Pediatric Patients With Neuroblastoma Using Volumetric Parameters of 18F-FDG and 18F-DOPA PET/CT.
    Liu CJ; Lu MY; Liu YL; Ko CL; Ko KY; Tzen KY; Chang HH; Yang YL; Jou ST; Hsu WM; Yen RF
    Clin Nucl Med; 2017 Mar; 42(3):e142-e148. PubMed ID: 28072621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of metabolic indices and bone marrow uptake pattern on preoperative 18F-FDG PET/CT in pediatric patients with neuroblastoma.
    Li C; Zhang J; Chen S; Huang S; Wu S; Zhang L; Zhang F; Wang H
    Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):306-315. PubMed ID: 29110068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of pretreatment 18F-FDG PET/CT in prognosis and the reflection of tumor burden: a study in pediatric patients with newly diagnosed neuroblastoma.
    Man S; Yan J; Li J; Cao Y; Hu J; Ma W; Liu J; Zhao Q
    Int J Med Sci; 2021; 18(8):1857-1865. PubMed ID: 33746603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis, Treatment Response, and Prognosis: The Role of
    Piccardo A; Morana G; Puntoni M; Campora S; Sorrentino S; Zucchetta P; Ugolini M; Conte M; Cistaro A; Ferrarazzo G; Pescetto M; Lattuada M; Bottoni G; Garaventa A; Giovanella L; Lopci E
    J Nucl Med; 2020 Mar; 61(3):367-374. PubMed ID: 31541036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of ¹⁸F-DOPA PET/CT at the time of recurrence in patients affected by neuroblastoma.
    Piccardo A; Puntoni M; Lopci E; Conte M; Foppiani L; Sorrentino S; Morana G; Naseri M; Cistaro A; Villavecchia G; Fanti S; Garaventa A
    Eur J Nucl Med Mol Imaging; 2014 Jun; 41(6):1046-56. PubMed ID: 24562643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of texture analysis of the primary tumour in high-risk neuroblastoma: An
    Fiz F; Bottoni G; Bini F; Cerroni F; Marinozzi F; Conte M; Treglia G; Morana G; Sorrentino S; Garaventa A; Siri G; Piccardo A
    Pediatr Blood Cancer; 2022 Nov; 69(11):e29910. PubMed ID: 35920594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic imaging in recurrent gliomas: comparative performance of 18F-FDOPA, 18F-fluorocholine and 18F-FDG PET/CT.
    Sharma A; Garg A; Singh M; Sharma MC; Gupta S; Kunhiparambath H; Tripathi M; Kale SS; Bal C
    Nucl Med Commun; 2024 Feb; 45(2):139-147. PubMed ID: 38095139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic FDG and FDOPA positron emission tomography scans distinguish the genomic type and treatment outcome of neuroblastoma.
    Liu YL; Lu MY; Chang HH; Lu CC; Lin DT; Jou ST; Yang YL; Lee YL; Huang SF; Jeng YM; Lee H; Miser JS; Lin KH; Liao YF; Hsu WM; Tzen KY
    Oncotarget; 2016 Apr; 7(14):18774-86. PubMed ID: 26959748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of 18F-FDG PET/CT-Metabolic Parameters at Baseline and Interim Assessment in Pediatric Anaplastic Large Cell Lymphoma.
    Mathew B; Vijayasekharan K; Shah S; Purandare NC; Agrawal A; Puranik A; Prasad M; Narula G; Banavali S; Rangarajan V
    Clin Nucl Med; 2020 Mar; 45(3):182-186. PubMed ID: 31977486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of pretreatment
    Sung AJ; Weiss BD; Sharp SE; Zhang B; Trout AT
    Pediatr Radiol; 2021 Jul; 51(8):1400-1405. PubMed ID: 33629142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT.
    Piccardo A; Puntoni M; Morbelli S; Massollo M; Bongioanni F; Paparo F; Altrinetti V; Gonella R; Gennari A; Iacozzi M; Sambuceti G; DeCensi A
    Nuklearmedizin; 2015; 54(4):163-72. PubMed ID: 26165806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Various Metabolic Parameters Derived From Baseline 18F-FDG PET/CT as Prognostic Markers in Non-Small Cell Lung Cancer Patients Undergoing Platinum-Based Chemotherapy.
    Sharma A; Mohan A; Bhalla AS; Sharma MC; Vishnubhatla S; Das CJ; Pandey AK; Sekhar Bal C; Patel CD; Sharma P; Agarwal KK; Kumar R
    Clin Nucl Med; 2018 Jan; 43(1):e8-e17. PubMed ID: 29112011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDG PET/CT for Prognostic Stratification of Patients With Extranodal Natural Killer/T-Cell Lymphoma.
    Qin C; Yang S; Sun X; Xia X; Li C; Lan X
    Clin Nucl Med; 2019 Mar; 44(3):201-208. PubMed ID: 30624268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic parameters of sequential 18F-FDG PET/CT predict overall survival of esophageal cancer patients treated with (chemo-) radiation.
    Li Y; Zschaeck S; Lin Q; Chen S; Chen L; Wu H
    Radiat Oncol; 2019 Feb; 14(1):35. PubMed ID: 30782182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of pretreatment FDG PET in pediatric neuroblastoma.
    Lee JW; Cho A; Yun M; Lee JD; Lyu CJ; Kang WJ
    Eur J Radiol; 2015 Dec; 84(12):2633-9. PubMed ID: 26462795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer.
    Miccò M; Vargas HA; Burger IA; Kollmeier MA; Goldman DA; Park KJ; Abu-Rustum NR; Hricak H; Sala E
    Eur J Radiol; 2014 Jul; 83(7):1169-1176. PubMed ID: 24767630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.
    Liao S; Penney BC; Wroblewski K; Zhang H; Simon CA; Kampalath R; Shih MC; Shimada N; Chen S; Salgia R; Appelbaum DE; Suzuki K; Chen CT; Pu Y
    Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):27-38. PubMed ID: 21946983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative Standardized Uptake Value of Metastatic Lymph Nodes Measured by 18F-FDG PET/CT Improves the Prediction of Prognosis in Gastric Cancer.
    Song BI; Kim HW; Won KS; Ryu SW; Sohn SS; Kang YN
    Medicine (Baltimore); 2015 Jul; 94(26):e1037. PubMed ID: 26131811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.